Standardized e-cigarette tested against usual brands in nicotine study

NCT ID NCT05658471

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how nicotine is absorbed and affects the body when using a standardized research e-cigarette compared to a person's usual brand e-cigarette. Thirty-two regular e-cigarette users participated in a crossover study where they used both types. Researchers measured nicotine levels in the blood, puffing patterns, and feelings of satisfaction or withdrawal. The goal was to see if the research e-cigarette can be a reliable tool for future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
nicotine
What this could lead to
If successful, this could help standardize research e-cigarettes for future studies on nicotine exposure and health effects.
What could go wrong
This is a small, completed study with only 32 participants, so results may not apply to all e-cigarette users. It does not test long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR RISK FACTORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco - Tobacco Research Center

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.